Identification of Diabetic Macular Oedema Patients and Compilation of an Algorithm for Differential Treatment with Brolucizumab

Abstract

Among the generally recognised methods of diabetic macular oedema (DMO) diagnosis, optical coherence tomography (OCT) is the most sensitive one, which provides reliable, reproducible, objective retinal images, replacing subjective assessments, and is considered as a kind of lifetime retinal biopsy. In contrast to the applied clinical studies, OCT allows to detect structural changes of the retina at early stages of AMD, during laser treatment, to quantify them with the lowest variability of parameters, to identify retinal layers with high resolution.